ARTICLE | Financial News
TG Therapeutics completes follow-on
March 10, 2017 8:11 PM UTC
On March 9, cancer and autoimmune company TG Therapeutics Inc. (NASDAQ:TGTX) raised $50 million through the sale of 5.1 million shares at $9.75 in a follow-on underwritten by Jefferies, SunTrust, Lad...
BCIQ Company Profiles